Project Grant HT94252510895
- The U.S. Defense Health Agency awarded a $4,613,247 Project Grant to the Western Institute For Veterans Research, a non-profit organization, for the "SHINING LIGHT ON TRAUMA: TREATMENT OF CHRONIC TBI TO IMPROVE PSYCHOLOGICAL HEALTH USING PHOTOBIOMODULATION IN SERVICE MEMBERS, VETERANS AND FIRST RESPONDERS" program. The grant, awarded under the Military Medical Research and Development (CFDA 12.420) federal grant program, will support advanced biomedical research to transform healthcare...
- The Oregon Health & Science University was awarded a $249,308 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of April 1, 2021 through March 31, 2024. The grant aims to support research titled "IANAM: THE ABILITY TO "VISUALIZE" HEADACHE, SLEEP DISTURBANCE, AND MTBI" which investigates medical solutions for conditions experienced by military service members, such as traumatic brain...
- The Oregon Health & Science University (OHSU) was awarded a $644,570 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year grant will fund the TBI Exosomal Activity in Military Personnel: Perivascular Space and Role of Indicators of Sleep Metrics (TEAM-PRISM) project. Through this funding, OHSU researchers will investigate medical solutions for traumatic brain injury on the battlefield by exploring the role...
- The U.S. Department of the Army Medical Command awarded a $1,277,097 Project Grant to Oregon Health & Science University (OHSU) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "GLIMPSE-PD: GLYMPHATICS IMAGING TO PROBE SLEEP IN PARKINSON'S DISEASE," aims to support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The project will run from Sep...
- This federal Project Grant award of $2,217,454.00, awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports a research study on the effects of transcranial photobiomodulation (PBM) in older adults with traumatic brain injury. The primary awardee is the Research Foundation of the City University of New York, which is collaborating with New York University School of Medicine as a sub-grantee. The research aims to...
- The University of Colorado received a $1.5 million Project Grant award from the Department of the Army Medical Command to investigate the role of microglia in sleep disturbances following a traumatic brain injury. The research will be conducted from July 2022 through June 2026 under the Military Medical Research and Development program (CFDA 12.420). This program supports basic, applied, and advanced biomedical research with the goals of improving military and civilian healthcare through...
- The Department of the Army Medical Command awarded a $777,315 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support the development of a novel noninvasive near-infrared light treatment for traumatic brain injury. Specifically, the University of Michigan will work to translate technology that uses specific infrared wavelengths to modulate mitochondrial function and limit reactive...
- The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
- This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
- This $1,000,000.00 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research focused on investigating whether the gut microbiome coordinates with the gut-brain axis to contribute to behavioral alterations and cognitive injuries following traumatic brain injury (TBI), and if these effects are more profound in individuals with the APOE E4 genetic variant. The prime...
This Project Grant award of $4,981,294.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) aims to study the use of light therapy to improve sleep in veterans with traumatic brain injury (TBI). The award was granted to Oregon Health & Science University (OHSU) and will fund research on sleep-active biomarkers and glymphatic function over the period from October 1, 2025 to September 30, 2029. The research seeks to advance understanding of the relationship between light therapy, sleep, and neurological outcomes in veterans with TBI, with the goal of developing new treatment approaches. This grant reflects the program's focus on supporting innovative biomedical research to transform healthcare for military service members, veterans, and the broader public.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $5.0m | 8/12/25 |